Zogenix, Inc. has been acquired by UCB.   Learn More

Rare Disease TherapiesTogether, we can bring hope and support to families impacted by rare diseases.

Our Story

Zogenix is committed to developing and commercialising transformative therapies to improve the lives of patients and their families living with rare diseases.

Clinical Trials

To view our open or completed clinical trials, please visit www.clinicaltrialsregister.eu (EU) or www.clinicaltrials.gov (U.S.) and search Zogenix.